Join
Live feed
·
NEWSReleasevia Quantisnow
Virios Therapeutics Inc. logo

Virios Therapeutics Announces Completion Of Enrollment In Proof Of Concept Long-COVID Study; Top Line Results Expected In October 2024; Study Highlights Potential For Antiviral Therapy To Treat Long-COVID Symptoms

ByQuantisnow·Wall Street's wire, on your screen.
VIRI· Virios Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRI (Virios Therapeutics Inc.) and more on Quantisnow.